Being less known Pharma company to investors, study shows promoters have 40 years of experience and established in critical care business. Plan to launch Hep A will give boost to sales and profit in future. Considering financial and prospects for hep A, good investment for long term only
2.1. DownriteVJ| Link| Bookmark|
January 30, 2020 1:07:21 PM
IPO Guru (1400+ Posts, 1200+ Likes)
If so much experience why is still a lesser known company.